期刊文献+

新型正性肌力活性物PHR0007对离体蟾蜍心肌收缩力的影响 被引量:1

Effects of a novel positive inotropic agent PHR0007 on the contractile force of the isolated cardiac muscle in toads
下载PDF
导出
摘要 [目的]观察和探讨新型正性肌力活性物PHR0007(三唑并二氢喹啉衍生物)对离体蟾蜍心肌收缩力的影响及其机制.[方法]单用PHR0007(1,3,10μmol/L,1mL/只)、米力农(10μmol/L,1mL/只)、合用PHR0007(10μmol/L)和米力农(10μmol/L)以及追加20g/L氯化钙溶液(30μL)灌注给予离体蟾蜍心脏后,观察心肌收缩力的变化情况.[结果]与空白对照比较,在PHR0007浓度在1~10μmol/L范围内时心肌收缩力增加1.28~1.35倍,并与剂量成正比(r=0.941),单用米力农使心肌收缩力增加1.39倍,合用米力农和PHR0007使心肌收缩力增加1.42倍,追加20g/L氯化钙使心肌收缩力增加1.73倍.[结论]PHR0007具有正性肌力作用,其机制可能与米力农相似或相同. OBJECTIVE To investigate the effects of PHR 0007 ([-1,2,4] triazolo [4,3-a] quinoline derivative) on the contractile force of the isolated toad's cardiac muscles. METHODS Isolated toad hearts were infused with the single doses of PHR 0007 (1, 3 or 10μmol/L, 1 mL of each) and a single dose of milrinone (10μmol/L, 1 mL of each), or in combination of PHR 0007 (10μmol/L) with milrinone (10 μmol/L), followed with 20 g/L calcium chloride(30 μL), and the contractile force, heart rate, and rhythm of the toad's cardiac muscles were detected with tension transducer which was connected with BL-420 biological function processing system. RESULTS PHR 0007 increased the contractile force of the toad's cardiac muscles. Compared to the control, PHR 0007 at the concentration between 1 9mol/L and 10/zmol/L increased the contractile force 1.28 - 1.35-fold concentration-dependently (r = 0. 941), and 1/xmol/L of milrinone also increased the contractile force to 1.39-fold. Combination of PHR 0007 with milrinone increased the contractile force only to 1.42-fold, which was not enhanced significantly than the single dose of PHR 0007 or milrinone. But the addition of calcium chloride elevated to 1.73-fold, which was 1.21-fold higher than the combination. CONCLUSION PHR 0007 enhance the contractile force of the isolated toad's cardiac muscle without disturbance of the heart rate and rhythm. The positive inotropic mechanism of PHR 0007 may be the same as that of milrinone.
出处 《延边大学医学学报》 CAS 2009年第1期8-10,共3页 Journal of Medical Science Yanbian University
基金 国家自然科学基金(30560177)
关键词 强心药 收缩 心肌 蛙科 gardiotonic agents constriction myocardium ranidae
  • 相关文献

参考文献5

二级参考文献15

  • 1廖新成.1-苯甲酰基哌嗪的制备[J].中国医药工业杂志(信息版),1993,(1):21-21.
  • 2邓大为.新型正性肌力药Piperanometozine及其衍生物的合成研究:(硕士论文)[M].成都:华西医科大学,1988..
  • 3邓大为,硕士学位论文,1988年
  • 4廖新成,中国医药工业杂志,1993年,1期,21页
  • 5徐叔云,药理实验方法学(第2版),1991年,866页
  • 6徐叔云,药理实验方法学(第2版),1991年,984页
  • 7PAPP JG. Introduction: positive inotropy by calcium sensitization- an evolving approach for the treatment of end-stage heart failure[J]. Am J Cardiol, 1999, 83(12B):1-3.
  • 8PACKER M , CARVER JR, RODEHEFFER RJ, et al. Effect of milrinone on mortality in severe chronic heart failure[J]. N Engl J Med, 1993, 325(21):1468-1475.
  • 9HASENFUSS G, PIESKE B, CASTELL M, et al. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium[J]. Circulation, 1998, 98(20):2141-2147.
  • 10HAIJALA VP, PEUHKURINEN K, NIEMINEN MS, et al. Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure[J]. Am J Cardiol, 1999, 83(12B):4-8.

共引文献23

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部